Related Experiment Videos
Expression of c-kit protooncogene in human hepatocellular carcinoma
Chih-Yuan Chung1, Kun-Tu Yeh, Nicholas C Hsu
1Division of Hematology-Oncology, Department of Internal Medicine, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua 500, Taiwan, ROC.
Cancer Letters
|December 25, 2004
Summary
The c-kit protooncogene is expressed in some hepatocellular carcinoma (HCC) cases. Positive c-kit expression in HCC tumors correlates with improved patient survival, suggesting its potential as a prognostic marker.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- The role of specific protooncogenes, like c-kit, in HCC development and progression requires further elucidation.
Purpose of the Study:
- To investigate the expression of the c-kit protooncogene in human hepatocellular carcinoma (HCC).
- To determine the correlation between c-kit expression and patient prognosis in HCC.
Main Methods:
- Immunohistochemical staining (IHC) was used to detect c-kit protein expression in HCC tissues.
- Reverse transcription-polymerase chain reaction (RT-PCR) was employed to confirm c-kit mRNA transcripts.
- Statistical analysis was performed to correlate c-kit expression with patient survival data.
Main Results:
- C-kit protein expression was detected in 25.6% (22 out of 86) of HCC tissue samples.
- C-kit mRNA was confirmed in all c-kit protein-positive HCC samples.
- Patients with c-kit positive HCC showed significantly better survival rates compared to those with negative c-kit expression (p=0.021).
Conclusions:
- C-kit protooncogene is expressed in a subset of human HCC.
- C-kit expression in HCC is associated with a favorable prognosis.
- C-kit may serve as a valuable prognostic biomarker for hepatocellular carcinoma.